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Guided by dentin biomechanical bioactivity, this phytochemical study led to the elucidation of an 
extended set of structurally demanding proanthocyanidins (PACs). Unambiguous structure 
determination involved detailed spectroscopic and chemical characterization of four A-type dimers 
(2 and 4–6), seven trimers (10–16), and six tetramers (17–22). New outcomes confirm the feasibility of 
determining the absolute configuration of the catechol monomers in oligomeric PACs by one-
dimensional (1D) and two-dimensional (2D) NMR. Electronic circular dichroism as well as 
phloroglucinolysis followed by mass spectrometry and chiral phase high-performance liquid 
chromatography (HPLC) analysis generated the necessary chiral reference data. In the context of 
previously reported dentin-bioactive PACs, accurately and precisely assigned 13C NMR resonances 
enabled absolute stereochemical assignments of PAC monomers via (i) inclusion of the 13C NMR γ-
gauche effect and (ii) determination of differential 13C chemical shift values (ΔδC) in comparison with 
those of the terminal monomer (unit II) in the dimers 2 and 4–6. Among the 13 fully elucidated PACs, 
eight were identified as new, and one structure (11) was revised based on new knowledge gained 
regarding the subtle, stereospecific spectroscopic properties of PACs. 
Introduction 
Proanthocyanidins (PACs) are a structurally diverse and complex group of condensed, oligomeric 
flavan-3-ols that are widespread in woody and some herbaceous plants.(1) PACs contain several 
subtypes such as procyanidins, prodelphinidins, and propelargonidins based on the corresponding 
basic units catechin and epi-catechin (syn. epicatechin), gallocatechin and epi-gallocatechin (syn. 
epigallocatechin), and afzelechin and epi-afzelechin (syn. epiafzelechin).(2) B-type PACs have one 
interflavanyl bond originated from coupling C-4 with one of the nucleophilic C-6 or C-8 of a subsequent 
monomer. A-type PACs have an additional ether bond between C-2 in the “top” and an A-ring hydroxyl 
moiety in the “bottom” unit. Since their discovery in 1947, PACs have attracted scientific attention for 
their complicated structures and medicinal values.(3) While PACs have been associated with a broad 
spectrum of bioactivities, including antioxidant,(4) anticancer,(5) anti-
inflammatory,(6) antidiabetic,(7) neuroprotective(8) effects, and play an important role in the fields of 
nutrition and health. The focus of our research at the chemistry–dentistry interface has been the 
exploration and understanding of their structure-specific abilities to enhance the biomechanical 
properties of dentin, the collagenous tissue of teeth.(9−11) 
The structural complexity of PACs increases exponentially with their degree of polymerization (DP), the 
linkages (A- and B-type), and absolute configuration of their interflavanyl linkages (IFLs), as well as the 
combination of the possible stereoisomeric monomers. Additional analytical challenges are posed by 
the formation of atropisomers, which interferes with chromatographic separation and often makes 
NMR spectra acquired at room temperature uninterpretable because of exceedingly broad lines. 
Additionally, in some cases, resonances can be “missing” because of H–D exchange in deuterated NMR 
solvents, even for hydrogens that might initially be considered “not likely to 
exchange.”(9−11) Collectively, these properties make the structural elucidation of trimeric or higher 
oligomeric PACs an often challenging undertaking. In general, reliance on the literature data is 
hazardous as structure-related publications seldom report full assignment of the 1H and 13C NMR data. 
This provides grounds for questioning the ultimate reliability of at least some PAC structures and their 
spectroscopic assignments and rationalizes the importance of developing highly cohesive data sets. 
Pinus massoniana is a pine species within the Pinaceae family that has a PAC-rich inner bark. Our 
previous studies showed that P. massoniana PACs can specifically enhance dentin biomechanical 
properties and reduce proteolytic dentin degradation.(9−11) Studies of PACs action on dentin initially 
established that the affinity of PACs for type-I collagen correlates with the DP and certain 
structural/stereochemical features.(9−11) These previous studies showed that tri- and tetrameric PACs 
are the most promising dentin strengthening agents. Accordingly, this study was focused on 
phytochemical isolation and structural analysis of tri- and tetrameric PACs from P. massoniana pine 
bark. Carried out in a scaled-up operation, the goal was to provide solid structural evidence for these 
PACs and sufficient amounts of the most bioactive PAC oligomers required to explore their mechanism 
of action on dentin, including a variety of biomechanical properties such as static and dynamic 
stiffness, biodegradation resistance, and resin bonding properties. 
In addition to the four known A-type dimers, epicatechin-(2β → O → 7,4β → 8)-catechin 
(2),(9) epicatechin-(2β → O → 7,4β → 8)-epicatechin (4),(9) epicatechin-(2β → O → 7,4β → 8)-ent-
catechin (5),(10) and epicatechin-(2β → O → 7,4β → 8)-ent-epicatechin (6)(10) reported previously 
from this plant, seven trimers (10–16) and six tetramers (17–22) were isolated and characterized 
(Figure 1). Among these 13 PACs, eight are new structures, and one (11)(9) was revised based on new 
NMR evidence. In order to achieve rigorous structural evidence for these PACs, the following strategies 
were applied: (i) all NMR data sets were acquired at low temperatures (278 and/or 255 K) to achieve 
assignable spectra with high resolution, (ii) two-dimensional (2D) heteronuclear single quantum 
coherence, heteronuclear multiple bond correlation (HMBC), and nuclear Overhauser enhancement 
spectroscopy (NOESY) spectra were used to establish the planar structures; particularly, 4 → 6 and 4 → 
8 IFLs can be distinguished from the NOESY data, by the differential chemical shifts of the C-6 and C-8 
atoms in the monomers. The absolute configuration of the constituent monomers were determined by 
a combination of (iii) NMR evidence involving NOESY correlations, the “γ-gauche effect” in the 13C 
domain, differential 13C chemical shift (ΔδC) values relative to the four stereochemically fully 
characterized dimers (terminal unit II), (iv) electronic circular dichroism (ECD) data, and (v) 
phloroglucinolysis combined with liquid chromatography–mass spectrometry (MS) and chiral phase 
high-performance liquid chromatography (HPLC) analysis (Figures 5 and S104–S106, Supporting 
Information). Factoring in previously reported NMR assignment, these spectroscopic and chemical 
methods allowed the unambiguous assignment of the structures of all isolated PACs. The presented 
detailed analytical profiles of 13 PACs (Tables 1–10, sorted by 1H/13C domains and increasing degree of 
oligomerization) enlarge significantly the space of the available NMR data of oligomeric PACs with solid 
structural information. This also expands the library of PACs that can be used to explore their dentin 
biomodification mechanisms of action systematically and supports the ongoing establishment of 
structure–activity relationships. 
 
Figure 1. Structures of 1–22. Compounds 1, 3, and 9 represent the phloroglucinol (PGN) adducts. 
Table 1. 1H and 13C NMR (400/100 MHz, resp.) Data of 1, 3, and 9 in CD3OD 
      1a  3b  9b  
unit ring no. δH mult (J in Hz) 13C δH mult (J in Hz) 13C δH mult (J in Hz) 13C 
I C 2 5.03, brs 77.1   100.1   100.3 
    3 3.89, dd (2.0, 1.0) 73.2 4.05, d, (3.4) 68.3 4.13, d, (3.5) 67.8 
    4 4.49, dd (2.0, 0.9) 37.0 4.45, d, (3.4) 29.5 4.20, d, (3.5) 29.5 
  A 5   157.6c   157.1   156.8 
    6 AB AB 6.03, d (2.4) 98.3 5.89, d (2.4) 98.0 
    7   157.8c   158.1   158.2 
    8 AB AB 6.08, d (2.4) 96.7 6.04, d (2.4) 96.5 
    9   158.1c   154.2   154.0 
    10   101.7   104.4   103.9 
  B 1′   132.7   132.6   132.4 
    2′ 6.87, d (1.9) 115.0 7.16, d (2.1) 115.7 7.13, d (2.2) 115.7 
    3′   145.8   145.6   145.6 
    4′   145.5   146.7   146.8 
    5′ 6.71, d (8.2) 115.7 6.82, d (8.4) 115.6 6.80, d (8.4) 115.6 
    6′ 6.71, dd (8.2, 1.9) 119.1 7.03, dd (8.4, 2.1) 119.8 7.01, dd (8.4, 2.2) 119.9 
II F 2     5.31, brs 79.1 4.54, d (9.8) 84.5 
    3     3.98, brd (1.9) 72.9 4.57, dd (9.8, 8.4) 73.0 
    4     4.56, brs 37.9 4.48, brd (8.4) 38.6 
  D 5       157.0   156.1 
    6     6.06, s 96.3 5.97, s 97.6 
    7       152.4   151.9 
    8       106.8   107.0 
    9       152.4   152.2 
    10       105.6   108.8 
  E 1′       131.8   131.3 
    2′     7.13, d (2.1) 116.2 7.07, d (2.1) 116.3 
    3′       145.9   146.2 
    4′       146.2   146.8 
    5′     6.80, d (8.3) 116.1 6.84, d (8.2) 116.2 
    6′     6.96, dd (8.3, 2.1) 120.6 6.95, dd (8.2, 2.1) 121.1 
phloroglucinol  1″   107.4   AB   107.5 
    2″ & 6″   158.7   AB   159.7 
    3″ & 5″ 5.75, s 95.1 AB AB 5.79, s 95.5 
    4″   160.0   AB   160.1 
aNMR data were acquired at 255 K. 
bNMR data were acquired at 298 K. 
cInterchangeable assignment; AB: absence of signals. 
 
Table 2. 13C NMR Data (CD3OD, 100 MHz) of Dimers 2 and 4–6 Acquired at Three Different Temperatures: 255, 278, and 298 K 
      2   4   5   6   
      δC   δC   δC   δC   
unit ring no. 298 K 278 K 255 K 298 K 278 K 255 K 298 K 278 K 255 K 298 K 278 K 255 K 
I C 2 100.28 100.22 100.13 100.16 100.05 99.94 100.40 100.32 100.24 100.42 100.37 100.30 
    3 67.74 67.75 67.71 68.06 67.99 67.98 67.64 67.56 67.50 67.73 67.70 67.65 
    4 29.16 29.13 29.12 29.23 29.13 29.05 29.22 29.12 29.03 29.23 29.17 29.07 
  A 5 156.71 156.78 156.84 156.99 156.98 157.00 156.66 156.63 156.64 156.70 156.73 156.72 
    6 98.14 98.01 97.83 98.29 98.11 97.92 98.14 98.02 97.89 97.95 97.84 97.71 
    7 158.08 158.11 158.06 158.11 158.03 158.00 158.12 158.10 158.05 158.10 158.10 158.05 
    8 96.52 96.39 96.26 96.61 96.49 96.36 96.58 96.47 96.35 96.54 96.43 96.31 
    9 154.19 154.19 154.16 154.24 154.18 154.14 154.08 154.02 153.98 154.14 154.12 154.06 
    10 104.00 103.89 103.76 104.25 104.12 103.98 104.03 103.91 103.80 104.06 103.97 103.86 
  B 1′ 132.24 132.22 132.15 132.43 132.34 132.28 132.21 132.10 132.01 132.30 132.24 132.16 
    2′ 115.66 115.59 115.48 115.65 115.54 115.43 115.71 115.60 115.50 115.63 115.53 115.43 
    3′ 145.59 145.61 146.70 145.64 145.57 145.52 145.65 145.59 145.55 145.65 145.64 145.60 
    4′ 146.73 146.74 145.56 146.75 146.67 146.62 146.80 146.74 146.69 146.78 146.76 146.72 
    5′ 115.62 115.51 115.41 115.54 115.53 115.43 115.63 115.54 115.43 115.70 115.67 115.52 
    6′ 119.81 119.77 119.71 119.78 119.72 119.67 119.85 119.79 119.74 119.85 119.8 119.75 
II F 2 84.41 84.43 84.36 81.73 81.60 81.48 83.87 83.80 83.75 80.82 80.74 80.61 
    3 68.06 68.09 68.10 66.96 66.93 66.97 68.38 68.32 68.29 67.13 67.10 67.05 
    4 28.90 29.04 29.04 29.88 29.87 29.90 28.83 28.84 28.90 29.46 29.51 29.55 
  D 5 156.09 156.15 156.14 156.59 156.55 156.56 156.15 156.14 156.16 156.62 156.65 156.66 
    6 96.52 96.39 96.20 96.48 96.31 96.12 96.52 96.37 96.22 96.46 96.30 96.14 
    7 152.14 152.19 152.20 152.28 152.24 152.24 152.21 152.17 152.16 152.06 152.05 152.02 
    8 106.75 106.69 106.60 107.20 107.10 107.03 106.54 106.40 106.29 106.92 106.84 106.75 
    9 151.36 151.41 151.42 152.13 152.13 152.18 150.83 150.80 150.79 151.28 151.28 151.27 
    10 103.09 103.01 102.89 102.41 102.28 102.21 102.81 102.69 102.58 101.89 101.78 101.66 
  E 1′ 130.51 130.47 130.39 131.19 131.18 131.22 130.92 130.77 130.63 131.40 131.37 131.33 
    2′ 115.71 115.65 115.56 115.92 115.79 115.64 115.42 115.30 115.18 115.20 115.07 114.91 
    3′ 146.29 146.30 146.25 145.97 145.88 145.81 146.41 146.35 146.33 146.20 146.2 146.16 
    4′ 146.73 146.74 146.70 146.28 146.17 146.08 146.75 146.70 146.69 146.20 146.17 146.11 
    5′ 116.31 116.22 116.10 116.03 115.92 115.81 116.34 116.24 116.14 116.19 116.09 115.98 
    6′ 120.68 120.66 120.64 120.37 120.29 120.18 120.33 120.30 120.31 119.42 119.30 119.15 
 
Table 3. 1H NMR Data of 10–14 (CD3OD, 800 MHz) 
      10a  11b 12b 13b 14b  
      δH mult (J in Hz)  δH mult (J in Hz) δH mult (J in Hz) δH mult (J in Hz) δH mult (J in Hz)  
unit ring no. rotamer A rotamer B major major major major A minor B 
I C 2 5.48, s 5.05, s 5.10, s 5.01, s       
    3 3.80, brs 3.88, brs 3.96, brs 3.89, brs 3.45, d (3.5) 3.46, d (3.5) 4.07, d (3.3) 
    4 4.64, brs 4.65, brs 4.82, brd (1.9) 4.77, brs 3.99, d (3.5) 3.99, d (3.5) 4.42, d (3.3) 
  A 6 5.86, d (1.7) 5.92, d (1.7) 6.00, brs 5.95, d (1.9) 5.92, d (2.4) 5.92, d (2.3) 6.01, d (2.3) 
    8 6.17, d (1.7) 5.98, d (1.7) 6.04, brs 5.98, d (1.9) 5.99, d (2.4) 5.99, d (2.3) 6.06, d (2.3) 
  B 2′ 6.93, d (2.1) 6.85, d (2.1) 6.87, d (1.8) 6.80, d (2.0) 7.08, d (2.2) 7.08, d (2.2) 7.14, d (2.2) 
    5′ 6.72, d (8.2) 6.68, d (8.2) 6.72, d (8.3) 6.66, d (8.2) 6.85, d (8.2) 6.85, d (8.2) 6.81, d (8.3) 
    6′ 6.61, dd (8.2, 2.
1) 
6.64, dd (8.2, 2.
1) 
6.68, dd (8.3, 1.
8) 
6.61, dd (8.2, 2.
0) 
6.93, dd (8.2, 2.
2) 
6.93, dd (8.2, 2.
2) 
7.02, dd (8.3, 2.
2) 
II F 2         5.51, s 5.56, s 5.39, s 
    3 4.05, d (3.6) 4.09, d (3.5) 4.18, d (3.5) 4.23, d (3.4) 4.04, brd (1.9) 4.06, brd (1.9) 4.00, brs 
    4 4.06, d (3.6) 4.19, d (3.5) 4.35, d (3.5) 4.49, d (3.4) 4.53, brs 4.54, brs 4.72, brs 
  D 6     5.98, s 5.85, s 5.82, s 5.83, s 6.08, s 
    8 6.20, s 6.03, s           
  E 2′ 7.09, d (2.2) 7.11, d (2.2) 7.35, d (2.0) 7.30, d (2.2) 7.23, d (2.1) 7.61, brd (8.7) 7.48, brd (8.6) 
    3′           6.86, brd (8.7) 6.81, brd (8.6) 
    5′ 6.81, d (8.1) 6.79, d (8.1) 6.85, d (8.1) 6.81, d (8.2) 6.84, d (8.2) 6.86, brd (8.7) 6.81, brd (8.6) 
    6′ 7.00, dd (8.1, 
2.2) 
7.01, dd (8.1, 
2.2) 
7.22, dd (8.1, 
2.0) 
7.19, dd (8.2, 
2.2) 
7.09, dd (8.2, 
2.1) 
7.61, brd (8.7) 7.48, brd (8.6) 
III I 2 4.36, d (9.4) 4.75, d (8.2) 4.78, d (7.9) 5.06, s 3.94, d (9.2) 3.96, d (9.1) 4.94, d (5.5) 
    3 4.20, ddd (10.0, 
9.4, 6.2) 
3.89, ddd (8.8, 
8.2, 5.6) 
4.20, ddd (8.4, 
7.9, 5.0) 
4.26, dd (4.3, 
2.0) 
3.66, ddd (10.3, 
9.2, 6.2) 
3.66, ddd (10.2, 
9.1, 6.2) 
4.13, m 
    4 2.47, dd (−16.2, 
10.0) 
2.57, dd (−16.2, 
8.8) 
3.02, dd (−16.2, 
5.0) 
2.87, dd (−16.9, 
2.0) 
2.41, dd (−16.1, 
10.3) 
2.41, dd (−16.1, 
10.2) 
2.63, m 
      3.08, dd (−16.2, 
6.2) 
3.00, dd (−16.2, 
5.6) 
2.62, dd (−16.2, 
8.4) 
2.94, dd (−16.9, 
4.3) 
3.04, dd (−16.1, 
6.2) 
3.04, dd (−16.1, 
6.2) 
2.63, m 
  G 6 6.11, s 6.11, s 6.09, s 6.03, s 6.09, s 6.10, s 5.86, s 
  H 2′ 6.74, d (2.2) 6.99, d (2.2) 6.98, d (1.6) 7.15, d (2.1) 6.75, d (2.0) 6.77, d (2.1) 6.87, d (2.2) 
    5′ 7.03, d (8.1) 6.86, d (8.1) 6.84, d (8.4) 6.84, d (8.2) 6.76, d (8.1) 6.73, d (8.1) 6.71, d (8.2) 
    6′ 6.79, dd (8.1, 
2.2) 
6.91, dd (8.1, 
2.2) 
6.88, dd (8.4, 
1.6) 
6.95, dd (8.2, 
2.1) 
6.67, dd (8.1, 
2.0) 
6.65, dd (8.1, 
2.1) 
6.88, dd (8.2, 
2.2) 
aNMR data were acquired at 255 K. 
bNMR data were acquired at 278 K. 
 
Table 4. 1H NMR Data of 15, 16, and 22 (CD3OD, 800 MHz) 
      15b  16c  22c 
      δH mult (J in Hz)  δH mult (J in Hz)  δH mult (J in Hz) 
unit ring no. major A minor B rotamer A rotamer B major 
I C 2 5.04, s 5.63, s       
    3 3.92, d (1.8) 3.96, d (1.8) 4.12, d (3.4) 4.09, d (3.4) 4.25, d (3.5) 
    4 4.65, d (1.8) 4.66, d (1.8) 4.21, d (3.4) 4.19, d (3.4) 3.91, d (3.5) 
  A 6 5.92, d (1.7) 5.86, brs 5.89, d (2.4) 5.89, d (2.4) 5.84, d (2.4) 
    8 5.98, d (1.7) 6.17, brs 6.04, d (2.4) 6.04, d (2.4) 6.03, d (2.4) 
  B 2′ 6.86, d (2.1) 7.00, d (2.1) 7.10, d (2.2) 7.11, d (2.2) 7.16, d (2.1) 
    5′ 6.70, d (8.1) 6.72, d (8.2) 6.79, d (8.3) 6.79, d (8.3) 6.80, d (8.2) 
    6′ 6.64, dd (8.1, 2.1) 6.88, dd (8.2, 2.1) 6.98, dd (8.3, 2.2) 6.99, dd (8.3, 2.2) 7.03, dd (8.2, 2.1) 
II F 2     4.57a 4.54a 4.34, d (9.8) 
    3 4.14, d (3.5) 4.00, d (3.6) 4.53a 4.51a 4.37, dd (9.8, 7.8) 
    4 4.33, d (3.5) 4.19, d (3.6) 4.55a 4.43, d (7.6) 4.44, d (7.8) 
  D 6     6.00, s 5.98, s 5.86, s 
    8 6.04, s 6.21, s       
  E 2′ 7.13, d (2.2) 7.10, d (2.2) 7.07, d (2.2) 7.07, d (2.2) 6.99, d (2.2) 
    5′ 6.82, d (8.1) 6.79, d (8.1) 6.84, d (8.2) 6.84, d (8.2) 6.89, d (8.1) 
    6′ 7.03, dd (8.1, 2.2) 6.99, dd (8.1, 2.2) 6.96, dd (8.2, 2.2) 6.96, dd (8.2, 2.2) 6.80, dd (8.1, 2.2) 
III I 2 4.95, s 4.76, s 4.50a 4.57a   
    3 4.17, m 3.98, m 3.97a 3.98a 4.14, d (3.6) 
    4 2.83, brd (−16.9) 2.79, brd (−16.5) 2.46, dd (−15.8, 8.4) 2.60, dd (−16.1, 8.2) 4.34, d (3.6) 
      3.00, dd (−16.9, 4.5) 2.90, dd (−16.5, 4.2) 2.78, dd (−15.8, 5.4) 2.91, dd (−16.1, 5.3)   
  G 6 6.13, s 6.12, s       
    8     6.00, s 5.90, s 6.18, s 
  H 2′ 7.29, d (2.2) 6.84, d (2.2) 6.84, d (2.0) 6.82, d (2.0) 7.13, d (2.2) 
    5′ 6.82, d (8.1) 6.97, d (8.1) 6.74, d (8.1) 6.75, d (8.1) 6.81, d (8.3) 
    6′ 6.99, dd (8.1, 2.2) 7.02, dd (8.1, 2.2) 6.72, dd (8.1, 2.0) 6.71, dd (8.1, 2.0) 7.02, dd (8.3, 2.2) 
IV L 2         5.21, brs 
    3         4.32, m 
    4         2.86, brd (−17.0) 
              2.96, dd (−17.0, 4.4) 
  J 6         6.07, s 
  K 2′         7.28, d (2.1) 
    5′         6.94, d (8.1) 
    6′         7.12, dd (8.1, 2.1) 
aSignals are overlapped. 
bNMR data were acquired at 255 K. 
cNMR data were acquired at 278 K. 
 
Table 5. 13C NMR Data of 10–16 (CD3OD, 100 MHz) 
      10a  11b 12b 13b 14b  15a  16b  
      δC  δC δC δC δC  δC  δC  
unit ring no. rotamer A rotamer B major major major major A minor B major A minor B rotamer A rotamer B 
I C 2 77.7 77.0 77.1 77.1 100.0 100.0 100.0 76.7 78.0 100.2 100.2 
    3 73.5 72.8 73.2 73.3 67.1 67.2 68.4 72.9 73.0 67.7 67.7 
    4 36.7 37.5 37.1 37.2 28.8 28.8 29.4 37.5 36.6 29.4 29.4 
  A 5 158.2 156.8 158.1 158.1 156.7 156.7 157.2 157.7 157.8 156.7 156.7 
    6 95.6 95.5 95.9 96.3 98.3 98.2 98.2 95.6 95.9 97.8 97.8 
    7 157.8 157.9 158.0 158.1 157.8 157.8 158.1 157.7 157.5 158.1 158.1 
    8 95.3 95.7 96.3 96.1 96.4 96.4 96.5 95.6 95.3 96.4 96.4 
    9 157.7 157.8 157.9 157.9 154.2 154.2 154.2 157.8 156.9 153.9 153.9 
    10 103.4 102.2 101.9 101.9 105.0 104.9 104.2 102.1 103.2 103.7 103.8 
  B 1′ 132.9 132.6 132.5 132.6 132.4 132.4 132.6 132.0 132.7 132.2 132.2 
    2′ 115.2 115.1 115.1 115.1 115.7 115.8 115.6 115.0 115.5 115.5 115.5 
    3′ 145.9 145.8 145.7 145.8 145.5 145.5 145.6 145.5 145.5 145.5 145.5 
    4′ 145.6 145.5 145.4 145.5 146.6 146.6 146.7 145.8 145.5 146.7 146.7 
    5′ 115.8 115.6 115.8 115.8 115.7 115.6 115.8 115.6 115.8 115.5 115.5 
    6′ 119.4 119.1 119.3 119.3 120.0 120.0 119.7 119.1 120.1 119.8 119.8 
II F 2 99.9 100.1 100.5 100.8 78.6 78.5 79.0 100.0 99.7 84.8 84.8 
    3 67.6 67.7 67.4 67.5 72.4 72.3 72.7 67.6 68.0 73.7 73.7 
    4 29.1 29.6 29.3 29.5 38.3 38.2 37.7 29.5 29.0 38.7 39.5 
  D 5 154.9 154.1 155.2 155.3 155.9 155.9 157.0 154.5 155.1 156.1 156.0 
    6 111.3 110.6 99.2 99.0 95.9 95.9 96.1 110.4 110.9 97.6 97.3 
    7 156.2 157.1 157.0 157.1 151.0 151.0 152.4 157.2 156.5 151.8 152.1 
    8 96.4 97.5 108.3 108.4 106.1 106.1 106.6 97.4 96.5 107.0 106.8 
    9 152.0 152.1 151.1 151.2 151.7 151.8 152.4 152.1 152.2 152.5 152.5 
    10 104.2 103.9 103.8 103.9 106.5 106.4 105.8 104.2 103.8 108.5 108.8 
  E 1′ 132.1 132.1 132.2 132.3 131.5 130.8 130.3 132.5 132.1 131.1 131.1 
    2′ 115.5 115.5 115.5 115.6 116.5 130.6 131.2 115.5 115.5 116.0 116.0 
    3′ 145.6 145.6 145.6 145.7 146.0 116.0 115.8 145.6 145.4 146.1 146.1 
    4′ 146.7 146.8 146.7 146.8 146.3 158.3 158.2 146.7 146.6 146.7 146.7 
    5′ 115.4 115.4 115.7 115.7 116.1 116.0 115.8 115.4 115.5 116.0 116.0 
    6′ 119.7 119.7 120.0 120.1 121.0 130.6 131.2 119.8 119.7 121.0 121.0 
III I 2 85.7 85.2 84.4 80.8 83.2 83.2 81.9 82.8 82.6 82.5 82.5 
    3 68.2 68.9 68.1 67.2 70.1 70.0 68.3 67.0 66.9 68.7 68.8 
    4 31.2 29.2 29.2 29.6 30.7 30.7 26.6 30.7 30.4 28.7 29.2 
  G 5 156.3 156.3 156.1 156.7 155.4 155.4 155.4 157.0 156.8 154.6 155.6 
    6 96.7 96.4 96.3 96.3 96.3 96.3 96.9 96.6 96.5 110.7 110.9 
    7 152.2 152.2 152.1 152.1 155.6 155.6 156.3 152.3 151.7 156.4 155.6 
    8 106.9 106.3 106.8 107.0 108.7 108.7 108.2 106.8 106.5 96.0 97.1 
    9 151.8 151.2 151.4 151.3 155.3 155.3 153.9 152.2 152.6 154.7 154.6 
    10 103.8 103.1 103.1 101.9 101.5 101.5 100.3 101.9 102.4 101.9 101.5 
  H 1′ 129.6 129.9 130.4 131.4 132.6 132.7 132.5 130.4 131.0 132.0 132.0 
    2′ 117.9 115.8 115.8 115.1 115.7 115.6 114.3 116.3 115.8 115.1 115.1 
    3′ 145.1 146.2 146.2 146.2 145.8 146.0 146.1 145.8 145.5 146.1 146.1 
    4′ 146.5 146.9 146.7 146.2 145.8 145.8 145.8 146.7 146.2 146.1 146.1 
    5′ 118.2 116.6 116.3 116.1 116.1 116.0 116.0 115.9 117.2 116.0 116.0 
    6′ 119.6 121.2 120.8 119.3 119.9 120.0 119.3 121.3 120.9 120.0 120.0 
aNMR data were acquired at 255 K. 
bNMR data were acquired at 278 K. 
 
Table 6. 1H NMR Data of 17–21 (CD3OD, 800 MHz, 278 K) 
      17 18 19  20  21  
      δH mult (J in 
Hz) 
δH mult (J in Hz) δH mult (J in Hz) δH mult (J in Hz) δH mult (J in H
z) 
δH mult (J in H
z) 
δH mult (J in H
z) 
δH mult (J in H
z) 
unit ring no. major major major A minor B major A minor B rotamer A rotamer B 
I C 3 4.10, d (3.3) 4.09, d (3.3) 4.09, d (3.3) 3.33, d (3.5) 4.08, d (3.3) 3.28, d (3.5) 4.05, d (3.27) 4.08, d (3.5) 
    4 4.45, d (3.3) 4.44, d (3.3) 4.44, d (3.3) 4.22, d (3.5) 4.42, d (3.3) 4.18, d (3.5) 4.39, d (3.31) 4.29, d (3.5) 
  A 6 6.04, d (2.4) 6.03, d (2.4) 6.04, d (2.3) 5.98, d (2.3) 6.02, d (2.3) 5.97, d (2.3) 6.00, d (2.34) 6.03, d (2.3) 
    8 6.09, d (2.4) 6.08, d (2.4) 6.08, d (2.3) 6.03, d (2.3) 6.07, d (2.3) 6.02, d (2.3) 6.05, d (2.34) 6.07, d (2.3) 
  B 2′ 7.15, d (2.1) 7.15, d (2.1) 7.15, d (2.1) 7.11, d (2.1) 7.15, d (2.1) 7.11, d (2.1) 7.12, d (2.1) 7.17, d (2.1) 
    5′ 6.82, d (8.3) 6.81, d (8.3) 6.82, d (8.3) 6.86, d (8.2) 6.82, d (8.2) 6.86, d (8.2) 6.79, d (8.2) 6.84, d (8.2) 
    6′ 7.03, dd (8.3, 
2.1) 
7.02, dd (8.3, 2.1
) 
7.04, dd (8.3, 2.1
) 
6.90, dd (8.2, 2.1
) 
7.03, dd (8.2, 2
.1) 
6.90, dd (8.2, 2
.1) 
7.00, dd (8.2, 2
.1) 
7.04, dd (8.2, 2
.1) 
II F 2 5.35, s 5.23, s 5.26, s 5.52, s 5.20, s 5.55, s 5.29, s 5.44, s 
    3 3.96, brd 
(2.3) 
4.00, brd (2.3) 3.97, brs 4.17, brs 3.92, brd (2.4) 4.18, brd (2.3) 3.89, brd (2.3) 3.84, brd (2.3) 
    4 4.74, brs 4.69, brs 4.82, brs 4.53, brs 4.80, brs 4.52, brs 4.55, brs 4.60, brs 
  D 6 6.07, s 6.07, s 6.11, s 5.86, s 6.10, s 5.84, s 6.00, s 5.90, s 
  E 2′ 7.12, d (2.1) 7.12, d (2.1) 7.06, d (2.1) 7.31, d (2.1) 7.05, d (2.1) 7.32, d (2.1) 7.07, d (2.1) 7.03, d (2.1) 
    5′ 6.78, d (8.2) 6.78, d (8.2) 6.76, d (8.2) 6.83, d (8.2) 6.73, d (8.2) 6.83, d (8.2) 6.75, d (8.2) 6.82, d (8.2) 
    6′ 6.94, dd (8.2, 
2.1) 
6.94, dd (8.2, 
2.1) 
6.91, dd (8.2, 
2.1) 
7.18, dd (8.2, 
2.1) 
6.84, dd (8.2, 
2.1) 
7.19, dd (8.2, 
2.1) 
6.89, dd (8.2, 
2.1) 
6.85, dd (8.2, 
2.1) 
III I 3 4.12, d (3.6) 4.13, d (3.6) 4.13, d (3.4) 3.68, d (3.2) 4.13, d (3.4) 3.68, d (3.2) 4.19, d (3.4) 4.20, d (3.4) 
    4 4.21, d (3.6) 4.33, d (3.6) 4.48, d (3.4) 4.17, d (3.2) 4.48, d (3.4) 4.37, d (3.2) 4.42, d (3.4) 4.31, d (3.4) 
  G 6     5.99, s 6.13, s 5.99, s 6.16, s     
    8 6.05, s 6.05, s         6.03, s 6.21, s 
  H 2′ 7.13, d (2.3) 7.13, d (2.3) 7.30, d (2.2) 7.03, d (2.3) 7.29, d (2.2) 7.02, d (2.2) 7.13, d (2.2) 7.132, d (2.2)  
    5′ 6.82, d (8.1) 6.82, d (8.1) 6.80, d (8.1) 6.79, d (8.3) 6.79, d (8.1) 6.78, d (8.1) 6.83, d (8.1) 6.81, d (8.1) 
    6′ 7.02, dd (8.1, 
2.3) 
7.02, dd (8.1, 
2.3) 
7.17 dd (8.1, 2.2) 7.01, dd (8.3, 
2.3) 
7.16, dd (8.1, 
2.2) 
7.00, dd (8.1, 
2.2) 
7.03, dd (8.1, 
2.2) 
7.02, dd (8.1, 
2.2) 
IV L 2 4.75, d (8.4) 4.96, brs 4.74, d (8.0) 4.69, d (8.1) 4.93, brs 4.90, brs 5.20, brs 4.94, brs 
    3 4.17, m 4.19, m 4.17, m 4.13, m 4.24, m 4.22, m 4.22, m 4.05, m 
    4 2.57, dd 
(−16.2, 9.1) 
2.84, brd (−17.0) 2.58, dd (−16.2, 
8.5) 
2.56, dd (−15.8, 
8.8) 
2.78a 2.78a 2.88a 2.85a 
      3.03, dd 
(−16.2, 5.4) 
2.99, dd (−17.0, 
4.6) 
2.98, dd (−16.2, 
5.4) 
2.97, dd (−15.8, 
5.5) 
2.95a 2.95a 2.91a 2.90a 
  J 6 6.12, s 6.14, s 6.04, s 6.16, s 6.04, s 6.15, s 6.10, s 6.11, s 
  K 2′ 6.99, d (2.1) 7.27, d (2.1) 6.94, d (2.1) 6.93, d (2.1) 7.19, d (2.1) 7.16, d (2.1) 7.09, d (2.1) 7.03, d (2.1) 
    5′ 6.87, d (8.1) 6.82, d (8.1) 6.84, d (8.1) 6.84, d (8.1) 6.81, d (8.1) 6.82, d (8.1) 6.80, d (8.1) 6.76, d (8.1) 
    6′ 6.94, dd (8.1, 
2.1) 
7.00, dd (8.1, 
2.1) 
6.86, dd (8.1, 
2.1) 
6.84, dd (8.1, 
2.1) 
7.02, dd (8.1, 
2.1) 
6.99, dd (8.1, 
2.1) 
6.93, dd (8.1, 
2.1) 
6.59, dd (8.1, 
2.1) 
aSignals are overlapped. 
Table 7. 13C NMR Data of 17–22 (CD3OD, 100 MHz, 278 K) 
      17 18 19  20  21  22 
      δC δC δC δC δC δC δC δC δC 
unit ring no. major major major A minor B major A minor B rotamer A rotamer B major 
I C 2 100.0 100.1 100.0 99.9 100.1 99.9 100.0 100.0 100.2 
    3 68.2 68.3 68.3 67.0 68.3 67.0 68.3 67.8 67.4 
    4 29.4 29.4 29.4 28.8 29.4 28.8 29.2 29.1 29.2 
  A 5 157.1 157.1 157.1 156.7 157.1 156.8 157.1 156.9 156.5 
    6 98.2 98.3 98.1 98.2 98.2 98.2 98.3 98.2 97.8 
    7 158.0 158.1 158.0 157.7 158.1 157.8 158.1 158.0 158.1 
    8 96.6 96.6 96.5 96.5 96.6 96.5 96.5 96.5 96.5 
    9 154.1 154.1 154.1 154.1 154.1 154.1 154.1 154.3 154.0 
    10 104.3 104.3 104.2 105.0 104.2 105.1 104.3 104.8 104.1 
  B 1′ 132.5 132.5 132.5 132.4 132.6 132.5 132.6 132.5 132.2 
    2′ 115.6 115.6 115.7 115.7 115.5 115.8 115.6 115.6 115.7 
    3′ 145.6 145.6 145.6 145.4 145.6 145.4 145.8 145.6 145.5 
    4′ 146.7 146.7 146.7 146.5 146.7 146.6 146.7 146.7 146.7 
    5′ 115.6 115.5 115.7 115.7 115.8 116.0 115.5–116.0 115.5–116.0 115.7 
    6′ 119.7 119.7 119.7 119.8 119.7 119.8 119.7 119.9 119.9 
II F 2 78.9 78.7 79.0 78.6 79.0 78.7 78.8 79.4 84.6 
    3 72.4 72.4 73.0 72.1 73.1 72.1 72.3 73.1 73.3 
    4 38.3 38.5 38.1 38.8 38.2 38.9 38.2 37.3 38.8 
  D 5 156.5 156.3 156.5 156.5 156.6 156.7 156.6 156.1 155.5 
    6 96.3 96.1 96.4 96.0 96.4 96.0 95.9 96.0 97.5 
    7 152.1 152.2 152.4 151.2 152.4 151.2 152.2 151.7 151.3 
    8 106.7 106.9 106.9 106.0 107.0 105.9 106.7 106.3 106.7 
    9 152.3 152.4 152.4 151.4 152.2 151.4 152.4 152.3 153.0 
    10 106.0 105.5 105.5 106.0 105.5 106.1 105.9 106.3 109.3 
  E 1′ 131.6 131.5 131.5 131.6 131.5 131.7 131.6 131.9 131.1 
    2′ 116.2 116.2 116.1 116.5 116.1 116.6 116.2 116.0 116.3 
    3′ 145.8 145.9 145.7 145.9 146.0 145.9 146.0 145.7 146.1 
    4′ 146.1 146.2 146.1 146.3 146.3 146.3 146.2 146.0 146.2 
    5′ 115.9 115.9 116.0 116.0 116.0 116.0 115.5–116.0 115.5–116.0 116.0 
    6′ 120.6 120.7 120.6 121.2 120.6 121.2 120.6 120.3 121.2 
III I 2 100.2 100.1 100.6 99.4 100.6 99.3 100.2 100.3 100.3 
    3 67.7 67.7 67.5 67.6 67.8 68.0 67.8 67.8 67.7 
    4 29.7 29.6 29.4 29.5 29.5 29.6 29.7 29.3 29.2 
  G 5 154.1 154.5 155.2 155.0 155.5 155.1 154.4 154.3 154.0 
    6 111.2 110.6 99.1 97.9 99.4 98.2 110.8 111.7 111.6 
    7 156.7 156.9 156.8 156.1 156.8 156.2 156.8 156.2 156.8 
    8 97.5 97.5 108.6 109.5 108.7 109.8 97.6 96.6 96.0 
    9 152.1 152.2 151.2 152.5 152.4 152.7 152.0 152.3 152.0 
    10 104.2 104.3 103.7 103.3 104.1 103.8 103.9 104.6 104.4 
  H 1′ 132.0 132.1 132.2 133.1 132.3 133.3 132.0 132.2 132.5 
    2′ 115.6 115.6 115.5 115.6 115.5 116.0 115.6 115.6 115.6 
    3′ 145.6 145.6 145.6 145.7 145.4 145.7 145.7 145.6 145.8 
    4′ 146.7 146.8 146.7 146.1 146.8 146.3 146.8 146.8 146.8 
    5′ 115.5 115.6 115.5 115.2 115.6 115.2 115.5–116.0 115.5–116.0 115.5 
    6′ 119.8 119.8 120.0 120.5 120.0 120.5 119.8 119.9 119.8 
IV L 2 85.1 82.7 84.5 84.5 81.8 81.7 80.9 81.1 80.9 
    3 68.2 66.9 68.1 68.2 66.8 67.0 67.2 67.3 67.5 
    4 29.2 30.5 29.1 29.2 30.0 30.0 29.5 29.4 29.5 
  J 5 156.2 157.0 156.1 155.8 156.7 156.4 156.7 156.7 156.8 
    6 96.6 96.7 96.4 96.5 96.5 96.5 96.5 96.8 96.5 
    7 152.1 152.2 152.2 152.9 152.2 153.0 152.2 151.9 152.0 
    8 106.4 106.8 106.8 107.4 107.2 107.8 106.7 106.9 106.7 
    9 151.3 152.2 151.3 150.7 152.4 151.5 151.0 151.1 151.0 
    10 103.1 102.2 103.1 102.5 102.3 101.7 101.7 101.7 101.9 
  K 1′ 130.0 130.5 130.4 130.4 131.3 131.1 131.3 131.5 131.8 
    2′ 116.3 116.6 115.7 115.7 116.0 115.8 115.0 114.9 114.8 
    3′ 146.1 145.9 146.2 146.2 146.1 146.0 146.2 146.0 146.2 
    4′ 146.9 146.7 146.7 146.7 146.0 146.3 146.3 145.4 145.3 
    5′ 116.8 116.1 116.0 116.0 115.8 115.8 115.5–116.0 116.6 116.8 
    6′ 121.3 121.4 120.8 120.7 120.4 120.2 119.4 119.3 119.5 
 
Table 8. Comparison of the 13C NMR Resonances of the Terminal Catechol Units in 12, 18, and 20–22 with Those of the Corresponding 
Carbons in 4 and 6a 




















no. δC δC δC ΔδC ΔδC δC ΔδC ΔδC δC ΔδC ΔδC δC ΔδC ΔδC δC ΔδC ΔδC 
2 80.74 81.60 80.79 0.05 –0.81 82.72 1.98 1.12 81.71 0.97 0.11 81.00 0.26 –0.60 80.91 0.17 –0.69 
3 67.10 66.93 67.16 0.06 0.23 66.90 –0.20 –0.03 66.94 –0.16 0.01 67.25 0.15 0.31 67.54 0.44 0.61 







































































































































































      0.64b –2.9   8.02 4.48b   4.72 1.18b   –
0.08b 
–4.17   0.61b –2.93 
a13C NMR data (100 MHz) were acquired in CD3OD with the temperature set as 278 K. 
bWith smaller ΣΔδC value. 
 
Table 9. Comparison of the 13C NMR Resonances of the Terminal Units in 10 and 15 with Those of the Corresponding Carbons 
in 2/5 and 4/6a 
  2 5 10 10 vs 2 10 vs 5 4 6 15 15 vs 6 15 vs 4 
no. δC δC avg δC ΔδC ΔδC δC δC avg δC ΔδC ΔδC 
2 84.36 83.75 85.45 1.09 1.70 81.48 80.61 82.66 2.05 1.18 
3 68.10 68.29 68.51 0.41 0.22 66.97 67.05 66.92 –0.13 –0.05 
4 29.04 28.90 30.17 1.13 1.27 29.90 29.55 30.55 1.00 0.65 
5 156.14 156.16 156.30 0.16 0.14 156.56 156.66 156.91 0.25 0.34 
6 96.20 96.22 96.56 0.36 0.34 96.12 96.14 96.54 0.40 0.42 
7 152.20 152.16 152.2 0.00 0.04 152.24 152.02 152.01 –0.01 –0.23 
8 106.60 106.29 106.595 0.00 0.30 107.03 106.75 106.60 –0.15 –0.43 
9 151.42 150.79 151.495 0.08 0.71 152.18 151.27 152.40 1.12 0.21 
10 102.89 102.58 103.41 0.52 0.83 102.21 101.66 102.19 0.53 –0.02 
1′ 130.39 130.63 129.74 –0.65 –0.89 131.22 131.33 130.69 –0.64 –0.53 
2′ 115.56 115.18 116.85 1.29 1.67 115.64 114.91 116.06 1.15 0.42 
3′ 146.25 146.33 145.67 –0.58 –0.66 145.81 146.16 145.67 –0.49 –0.14 
4′ 146.70 146.69 146.685 –0.01 0.00 146.08 146.11 146.43 0.32 0.35 
5′ 116.10 116.14 117.38 1.28 1.24 115.81 115.98 116.56 0.58 0.75 
6′ 120.64 120.31 120.375 –0.27 0.06 120.18 119.15 121.09 1.94 0.91 
ΣΔδC       4.80b 6.97       8.89 4.46b 
a13C NMR data (100 MHz) were acquired in CD3OD with the temperature set as 255 K. 
bWith smaller ΣΔδC value. 
 
Table 10. Comparison of the 13C NMR Resonances of the Terminal Units in 11, 17, and 19 with Those of the Corresponding Carbons 
in 2 and 5a 
  2 5 11 11 vs 2 11 vs 5 17 17 vs 2 17 vs 5 19 19 vs 2 19 vs 5 
no δC δC δC ΔδC ΔδC δC ΔδC ΔδC δC ΔδC ΔδC 
2 84.43 83.80 84.44 0.01 0.64 85.1 0.67 1.3 84.49 0.06 0.69 
3 68.09 68.32 68.08 –0.01 –0.24 68.18 0.09 –0.14 68.13 0.04 –0.19 
4 29.04 28.84 29.18 0.14 0.34 29.22 0.18 0.38 29.14 0.10 0.30 
5 156.15 156.14 156.09 –0.06 –0.05 156.15 0 0.01 155.98 –0.17 –0.16 
6 96.39 96.37 96.30 –0.09 –0.07 96.60 0.21 0.23 96.45 0.05 0.07 
7 152.19 152.17 152.11 –0.08 –0.06 152.08 –0.11 –0.09 152.52 0.33 0.35 
8 106.69 106.4 106.79 0.10 0.39 106.39 –0.3 –0.01 107.12 0.43 0.72 
9 151.41 150.80 151.36 –0.05 0.56 151.29 –0.12 0.49 151.00 –0.41 0.20 
10 103.01 102.69 103.11 0.10 0.42 103.08 0.07 0.39 102.80 –0.22 0.11 
1′ 130.47 130.77 130.37 –0.10 –0.40 129.95 –0.52 –0.82 130.43 –0.04 –0.34 
2′ 115.65 115.30 115.83 0.18 0.53 116.31 0.66 1.01 115.70 0.05 0.40 
3′ 146.30 146.35 146.21 –0.09 –0.14 146.11 –0.19 –0.24 146.20 –0.10 –0.15 
4′ 146.74 146.70 146.70 –0.04 0.00 146.92 0.18 0.22 146.70 –0.04 0.00 
5′ 116.22 116.24 116.28 0.06 0.04 116.78 0.56 0.54 116.00 –0.22 –0.24 
6′ 120.66 120.30 120.81 0.15 0.51 121.31 0.65 1.01 120.74 0.08 0.44 
ΣΔδC       0.22b 2.47   2.03b 4.28   –0.06b 2.19 
a13C NMR data (100 MHz) were acquired in CD3OD with the temperature set as 278 K. 
bWith smaller ΣΔδC value. 
 
Results and Discussion 
The present study focus on those fractions of the pine bark extract that were enriched in tri- and tetrameric PACs via a two-step centrifugal 
partition chromatography (CPC) based on dentin bioassay guidance.(9,10) In view of practical limitations posed by bioassay throughput and 
costs, one valuable means of targeting the isolation of these PACs is to distinguish them from other compounds by following their bright 
pink-red colored bands on Si gel thin-layer chromatography (TLC) plates after spraying with vanillin–sulfuric acid and heating. A multistep 
approach for the further purification of enriched bioactive fractions was applied to isolate the 13 PACs. The approach included Sephadex 
LH-20 and RP-18 column chromatography (CC) with eluents of different selectivity as well as semipreparative HPLC (see the Experimental 
Section). 
The isolation efforts focused on 12.1 g of enriched tri- and tetrameric PACs, obtained upon combining 6.5 g of fraction A and 5.6 g of 
fraction B that were prepared from 200 g of the pine bark extract by CPC, as described previously.(12) Dentin treated with both fractions A 
and B presented statistically higher apparent moduli of elasticity, as compared to control (p < 0.001), with an approximate 7- and 9-fold 
increase in the apparent modulus of elasticity values, respectively. No statistically significant differences occurred among the PAC-treated 
groups (p < 0.05; Figure 2). Considering a certain degree of overlap in constituents as per HPLC and TLC analysis, the materials were 
combined for the isolation of individual PACs. 
 
Figure 2. Mean and standard deviation of the apparent modulus of elasticity (MPa) of dentin specimens treated with the CPC fractions A and B. Different 
symbols depict statistical differences among groups (p < 0.05). 
 
Compounds 10 and 17 are the most abundant tri- and tetrameric PACs, respectively, in the investigated pine bark. Their structures are 
identical with those of the peanut procyanidins D and E,(13) as established by comparison of their 1H and 13C NMR data (Tables 3, 5–7). 
Phloroglucinolysis of 10 and 17 (Figure 5) further confirmed their structures. Purification of the phloroglucinolysis products resulted in the 
isolation of 1 and 2 from 10, as well as 2 and 3 from 17, respectively. In addition to dimer 2, the phloroglucinolysis monomer 1 and 
dimer 3 were used as stereochemical reference points in the subsequent structure elucidation of other trimers and tetramers. 
Compound 1 was assigned as 4-phloroglucinol substituted (ent)-epicatechin. Its molecular formula C21H18O9 was confirmed based on the 
(+)-HRESIMS [M + H]+ ion at m/z 415.1022 and the 13C NMR carbon counts (Table 1). The relative configuration of 1 was assigned as 2,3-cis-
3,4-trans, by comparing its 13C NMR resonances of C-2 (δC 77.1), C-3 (δC 73.2), and C-4 (δC 37.0) with the reported values.(14) The observed 
high-amplitude positive Cotton effect (CE) at 220–240 nm in the ECD spectrum (Figure 3A) of 1 showed that the 4-phloroglucinol group 
must be β-configured.(15−17) The absolute configuration of 1 was, thus, assigned as (2R,3R,4S)-epicatechin-(4β → 2)-phloroglucinol. 
 
Figure 3. ECD spectra of 1 (A) as well as 3, 4, and 6 [(B,C) showing expansions of the 260–300 nm region]. 
 
Compound 2 was identified by comparing its 1H and 13C NMR data (Table 2, Figure S6) and ECD (Figure S7) with the reported 
data.(9) However, based on the analysis of its 2D NMR data, the assignments of several carbon atoms in 2(9) should be revised as indicated. 
Compound 3 was recognized as a phloroglucinol-substituted A-type dimer, and its molecular formula was determined as C36H28O15 by the 
(+)-HRESIMS [M + H]+ ion at m/z 701.1504 and the 13C NMR data (Table 1). The ECD spectrum of 3 exhibited a high-amplitude positive CE in 
the region 220–240 nm (Figure 3B), which assigned the double linkages (2 → O → 7,4 → 8) and the 4-phloroglucinol moiety as being β-
oriented. Comparison of the ECD spectra of 3 with those of 4 and 6 revealed that compound 3 exhibited a negative CE in the region 280–
290 nm analogous to that of 4 (Figure 3C). The absolute configuration of (2R,3R) in unit II of 3 was thus determined.(15−17) Considering the 
diagnostic power of the γ-gauche effect, the upfield shifted C-2 (δC 79.1, ring F) when compared to the corresponding carbon in 4 (δC 81.5) 
suggested H-2 and H-4 to be trans-positioned.(18,19) This further corroborated the absolute configuration in unit II as being 2R, 3R. 
Accordingly, the structure of 3 had to be epicatechin-(2β → O → 7,4β → 8)-epicatechin-(4β → 2)-phloroglucinol or [PAC 4]-(4β → 2)-
phloroglucinol. 
Collectively, this evidence also assigned the structures of the major constituents, 10 and 17, unambiguously as being assembled by two 
corresponding moieties, 2 and 4, assigning them as the trimer, epicatechin-(4β → 6)-[PAC 2], and the tetramer, [PAC 4]-(4β → 6)-[PAC 2]. 
Compound 9 was purified from the phloroglucinolysis products of 16 and was identified as a phloroglucinol trapped A-type dimer, an 
assignment supported by its molecular formula C36H28O15 as confirmed by the (+)-HRESIMS [M + H]+ peak at m/z 701.1546 and the 13C NMR 
data (Table 1). Analyzing the 1H NMR spectra (Figure S16) of the phloroglucinolysis product of 17 revealed that its products were the same 
but present in different molar ratios when compared to those of 16. The products of 17 consisted of 3 as major and 9 as minor in terms of 
their molar ratio, while 9 was found as major and 3 as minor in phloroglucinolysis products of 16. Compounds 3 and 9 were, thus, assigned 
as C-2 epimerization products during phloroglucinolysis.(20) Accordingly, 9 was recognized as C-2 epimer of 3 and elucidated as [PAC 5]-(4β 
→ 2)-phloroglucinol. 
Compound 11 was isolated and identified in a previous study(9) in which the relative configuration of H-2 and H-4 in the C-ring was 
determined as being cis-configured based on the NOE between H-2 and H-4 observed in the NOESY spectrum. However, it is known that 
NOESY data can be ambiguous or inconclusive in the case of spin diffusion. As the previously reported 2,3-cis-3,4-cis relative configuration 
of natural PACs is rarely found in the literature, we challenged the prior evidence and pursued additional evidence to establish both the 
relative and absolute configuration. The upfield shifted C-2 (δC 77.1, C-ring; Table 5) when compared to the signal from the corresponding 
carbon in epicatechin (δC 79.1) suggested that H-2 and H-4 are in fact trans-positioned when considering earlier knowledge about the γ-
gauche effect.(18,19) Difference in the J3,4 values in 2,3-cis-3,4-cis-(3.8–4.5 Hz) versus 2,3-cis-3,4-trans-(1–2 Hz) configured moieties further 
indicated the need to revise the prior assignment of 11 because its J3,4 (ca. 1.9 Hz) was congruent with 2,3-cis-3,4-trans relative 
configuration.(14,21,22) Reductive cleavage of 11 by phloroglucinol formed compounds 1 and 2, which were verified by analysis of their MS 
data and chiral chromatograms (Figure 5). In summary of the new evidence, the structure of 11 should be revised to that of epicatechin-(4β 
→ 8)-[PAC 2]. 
Compound 12 shared the molecular formula C45H36O18 with 11 based on the (+)-HRESIMS [M + H]+ ion at m/z 865.1972 and the 13C NMR 
carbon counts. Comparison of the NMR data (Tables 3 and 5) revealed that 12 is structurally closely related with 11, with the major 
differences observed in resonances within unit III. Additionally, close similarities in the ECD curves of 12, especially the positive CE in the 
diagnostic 220–240 nm region (Figure 4A), as compared to the ECD of 11, suggested that the only differences between 12 and 11 were the 
configurations of C-2 and C-3 in unit III. A cis-configuration of III-H-2 and III-H-3 could be gleaned from the unresolved thus small J2,3 value. 
Accordingly, units II and III had to be linked like in PACs 4 or 6. Owing to the spatial distance between the upper unit I and the terminal unit 
III, the chemical shift impact of unit I on unit III had to be small, especially in the 13C domain because of the shielding of the molecular 
hydrogen “envelope.” Differential carbon chemical shift (ΔδC) could, thus, be used to determine the absolute configuration of unit III: units II 
and III were determined to be doubly connected as in 6 based on the close similarity of the 13C NMR data of the terminal unit III to that of 
the corresponding carbons in 6 (Table 8). Thereby, the structure of 12 including its absolute configuration was elucidated as epicatechin-(4β 
→ 8)-[PAC 6]. Although this structure had been reported earlier,(23) the insufficiency of the available NMR data and prior assignment puts 
its validity into question. Chiral phase HPLC and MS analysis of the phloroglucinolysis products of 12 further confirmed the compound to be 
assembled from dimer 6 and epicatechin (Figure S104). 
 
Figure 4. ECD spectra of the trimeric PACs 10–16 (A) and the tetrameric PACs 17–22 (B). 
 
The structure of 13 was established as that of cinnamtannin D1 by comparison of its 1H and 13C NMR data (Tables 3 and 5), as well as its ECD 
spectrum (Figure 4A) with the reported data.(24−26) Phloroglucinolysis dissociated 13 into two major compounds, 3 and catechin, the 
structures of which were verified by chiral phase HPLC and MS (Figure S104), collectively confirming 13 as [PAC 4]-(4β → 8)-catechin, 
previously named as cinnamtannin D1. 
Comparison of their NMR (Tables 3 and 5) and ECD data (Figure 4A) indicated that the structure of 14 was closely related with that of 13. 
The major difference was the presence of para-hydroxyphenyl signals in 14 versus the AMX 1H NMR resonances of 13. One pair of highly 
coupled signals (at δH 7.61 and 6.86, each 2H, br d, J = 8.6) was characteristic for a para-substituted phenyl, which was identified as a E-ring 
via HMBC correlations (Figure S41) connecting II-H-2′&6′ (δH 7.61) to II-C-2 (δC 78.5). Thus, 14 was shown to contain epiafzelechin as unit II, 
which was also consistent with the (+)-HRESIMS [M + H]+ peak at m/z 849.2045, 16 mass units less than that of 13. Collectively, the 
structure of 14 was assigned as II-3′–OH–nor-cinnamtannin D1. Phloroglucinolysis with chiral phase HPLC and MS data (Figure S105) 
affirmed the terminal unit III as catechin. 
Compound 15 exhibited a (+)-HRESIMS [M + H]+ peak at m/z 865.1960, corresponding to a molecular formula of C45H36O18, which was 
consistent with its 13C NMR data. Compound 15 was thus assigned as a trimeric PAC with one A- and one B-type IFL. Two major rotamers in 
a ∼3:1 ratio were observed in the 1H and 13C NMR spectra (Tables 4 and 5) acquired at low temperature (255 K) for restricted rotation 
around the B-type linkage.(9−11,13) The doubly linked interflavanyl bonds (2 → O → 7,4 → 8) between units II and III were verified by the 
HMBC correlations (Figure S54) from both II-H-4 (δH 4.33) and III-H-2 (δH 4.95) to III-C-9 (δC 152.2). Unit I was attached to unit II through a 4 
→ 6 bond as derived from the NOESY correlations from II-H-8/II-H-2′ and II-H-6′ (Figure S55), as well as the downfield shifted II-C-6 carbons 
(avg. δC 110.6).(13) The ECD data (Figure 4A) showed a high-amplitude positive CE at 220–240 nm, which assigned a β-configuration to the 
interflavanyl bonds. Both units I and III were confirmed as (ent)-epicatechin based on the singlet signals I-H-2 (δH 5.04/5.63, s) and III-H-2 
(δH 4.95/4.76, s). The upfield shifted chemical shift of the C-ring C-2 carbons (avg δC 77.4) suggested H-2 and H-4 to be trans-configured 
based on the γ-gauche effect.(18,19) Unit I was, thus, identified as epicatechin with a (2R, 3R)-absolute configuration. The 3,4-
trans configuration in the C-ring was assigned based on the NOESY correlation between II-H-3 and III-H-6.(16) Finally, the diagnostic 
ΔδC patterns were applied to determine the absolute configuration of the terminal unit III: it was identified as epicatechin as its 13C 
resonances were significantly closer to those of the corresponding carbons in 4 than to those in 6 (Table 9). To further confirm this 
conclusion, phloroglucinolysis of 15 was performed. The reaction products were identified as 1 and 4 by MS and chiral phase HPLC 
(Figure 5). Thus, compound 15 was unambiguously elucidated as epicatechin-(4β → 6)-[PAC 4]. While this structure has been reported 
previously,(27) the prior NMR data did not match the present data set. This mismatch can be explained by the incorrect assignment of II-C-
10 (δC 104.9) in the previous report,(27) which led to establishment of an incorrect 4 → 6 linkage through interpretation of HMBC 
correlations. The chemical shift previously reported for II-C-6 (δC 108.9) better matches the corresponding carbons in 11 and 12. This 
indicated that the compound reported earlier(27) in fact had a 4β → 8 IFL. Thus, its structure should be revised to epicatechin-(4β → 8)-
epicatechin-(4β → 8,2β → O → 7)-epicatechin.(28) However, considering the subtle substituent chemical shift (s.c.s.) effects uncovered in 
the present study, it is not surprising that the 13C NMR data corresponding to the structure of epicatechin-(4β → 8)-epicatechin-(4β → 8,2β 
→ O → 7)-epicatechin in refs (27) and (28) are inconsistent. Recognition of such inconsistencies and detection of potential misassignment in 
PAC structures remain challenging for authors and reviewers alike, and this emphasizes the urgent need for consolidated collections of raw 
NMR spectroscopic data.(29) 
 
Figure 5. Phloroglucinolysis products of selected 10, 11, 15, and 17–19 identified by chiral phase HPLC and MS analysis. 
 
The A + B-type trimeric PAC nature of 16 was supported by its molecular formula C45H36O18, which was established by the (+)-HRESIMS [M + 
H]+ peak at m/z 865.2007 and its 13C NMR data. Two sets of 1H NMR data (Table 4) representing two rotamers (∼1:1) were observed in the 
low temperature experiment at 278 K as indicative of the presence of atropisomers in PACs involving B-type IFLs. Both units II and III were 
identified as (ent)-catechin based on the J3,4 = 7.6 Hz for unit II and J3,4 = (8.4 and 5.4 Hz) for unit III. Units I and II were doubly linked as an A-
type dimer through 2 → O → 7/4 → 8 IFLs, as shown by the NOESY cross-peaks from II-H-2′ and II-H-6′ to I-H-4. The terminal unit III was 
shown to be linked to unit II by a 4 → 6 bond based on the shift of II-C-6 (δC 110.8) to lower field when compared to the corresponding 
carbons II-C-8 (δC 108.7) of cinnamtannin D1 and II-C-8 (δC 108.8) of aesculitannin B.(25) The β-configuration of both the 2 → O → 7/4 → 8 
and the 4 → 6 IFLs were assigned from the positive CE in the diagnostic region 220–240 nm (Figure 4A). Hydrogens II-H-2 and II-H-4 were 
determined to be cis-positioned based on the similar chemical shifts of II-C-2 (δC 84.7) and its corresponding carbon in 5 (δC 83.9). This also 
established the absolute configuration for unit II as 2S, 3R, and 4S. The absolute configuration of I-H-3 was assigned as R, based on the 
trans-orientation between I-H-3 and I-H-4. This assignment was verified by the NOESY correlation between I-H-3 and II-H-6. Finally, 
phloroglucinolysis was performed to determine the stereochemistry of the terminal unit III. Analysis of the reaction products revealed the 
presence of two major compounds: catechin (8) and compound 9 (Figure S105), which was found to be [PAC 5]-(4β → 2)-phloroglucinol. 
Thus, the structure of 16 was established as [PAC 5]-(4β → 6)-catechin. 
In addition to 17, five more 2A + B-type tetramers were isolated, as was gleaned from their identical molecular formulas 
C60H46O24 established via HRESIMS (Figures S70, S76, S82, S89, S96, and S103) and associated 13C NMR carbon counts. Comparison of their 
NMR (Tables 6 and 7) and ECD data (Figure 4B) revealed that 18 had the same planar structure as peanut procyanidin 
F.(13) Phloroglucinolysis of 18 led to the isolation of two major compounds 3 and 4, the structures of which were confirmed by MS and 
chiral phase HPLC (Figure 5). Thus, the structure of 18 was unambiguously determined as [PAC 4]-(4β → 6)-[PAC 4]. 
Analysis of the 1H and 13C NMR spectra of 19, recorded at 278 K, showed two major rotamers (1.3:1 ratio). Four pairs of resonances for AX 
spin systems were observed at δH 3.33 (d, J = 3.5 Hz), 4.22 (d, J = 3.5 Hz), 3.68 (d, J = 3.2 Hz), and 4.17 (d, J = 3.2 Hz) for rotamer A; and at 
δH 4.09 (d, J = 3.3 Hz), 4.44 (d, J = 3.3 Hz), 4.13 (d, J = 3.2 Hz), and 4.48 (d, J = 3.2 Hz) for rotamer B. This revealed the presence of two doubly 
linked A-type linkages. Three coupled methines (δH 5.52, 4.17, and 4.53 for rotamer A; and δH 5.26, 3.92, and 4.82 for rotamer B) indicated 
the presence of one B-type linkage, which must be located between units II and III as evident from the HMBC correlations (Figure S80) from 
II-H-4 to III-C-7 and III-C-9. Units II and IV were assigned as (ent)-epicatechin and (ent)-catechin based on the near 0 Hz value of J2,3 in the F-
ring and the 8.1 Hz J2,3 value in unit IV, respectively. The A-type linkage between units III and IV was confirmed as 2β → O → 7/4β → 8 via 
the HMBC correlation from IV-H-2 and III-H-4 to IV-C-9, as well as the positive CE at 220–240 nm in the ECD spectrum (Figure 3B). Similarly, 
the 2β → O → 7/4β → 8 linkage for units I and II was assigned via the NOESY correlations, as shown in Figure S81, between I-H-4 and II-H-2, 
supported by the ECD data. A 4β → 8 B-type linkage between units II and III was assigned by the NOESY correlations from II-H-4 to III-H-2′, -
5′, and -6′, as well as the chemical shifts of III-C-8 in the rotamers (avg. δC 109.2 vs 111.2 for 17). Trans-configuration for H-3 and H-4 was 
verified by the NOESY correlations from H-3 (C- and I-rings) to H-6 (D- and J-rings, respectively). Trans-positions of H-2 and H-4 in the F-ring 
was confirmed via the upfield shifted II-C-2 resonances (avg. δC 78.8) when compared to the corresponding carbon in 4 (δC 81.6). 
Comparison of the 13C NMR data of unit IV in 19 with the corresponding resonances in 2 and 5 showed that unit IV more closely resembles 
those in 2 (Table 10). Thus, 19 was confirmed as [PAC 4]-(4β → 8)-[PAC 2]. Assignment of MS data and chiral phase HPLC (Figure 5) was 
consistent with the structures of 3 and 2 as two major phloroglucinolysis products of 19 further confirmed this conclusion. 
The 1H and 13C NMR spectra of 20 highly resembled those of 19, including the presence of two rotamers in a ∼1.5:1 ratio and pointed to the 
terminal unit IV as the only major difference. The two A- and one B-type linkages in 20 were confirmed in analogy to those in 19 using 
HMBC (Figure S87), NOESY (Figure S88), ECD (Figure 4B), and 13C NMR data (Table 7). The terminal unit IV was identified as 2,3-cis-oriented 
(ent)-epicatechin based on the singlet like δH of IV-H-2 in the 1H NMR spectrum. Analysis of the 13C NMR data of unit IV showed that they 
are much more closely correlated with the corresponding carbons of 4 rather than those of 6 (Table 8). Thus, 19 was established as [PAC 4]-
(4β → 8)-[PAC 4], which was further confirmed by phloroglucinolysis (Figure S106). This structure was described previously, and the 
compound was named as aesculitannin G,(30) although no NMR data were reported. 
Based on the similarity of its 1H and 13C NMR data with those of 18, 21 was recognized as a PAC tetramer in which two A-type dimers were 
also connected through a B-type IFL. It also showed two major rotamers (∼1:1) in low temperature NMR at 278 K. Both A-type linkages 
between units I/II and III/IV were confirmed as being 2β → O → 7/4β → 8 via the NOESY correlations (Figure S95) from I-H-4 to II-H-2 and 
from III-H-4 to IV-H-2′/6′, respectively, as well as through observation of a strong positive CE at 220–240 nm in the ECD spectrum 
(Figure 4B). A 4β → 6 B-type linkage between units II and III was established by the ECD data and the NOESY correlations from III-H-8 to III-
H-2′/6′. The deduction was corroborated by the similar chemical shift of the III-C-6 carbons (avg. δC 111.2) relative to those of the 
corresponding carbons in 17 (avg. δC 111.2) and 18 (avg. δC 110.9), which were significantly different from those in 19 (avg. δC 109.0) 
and 20 (avg. δC 109.2). Unit IV was identified as ent-epicatechin based on the closer resemblance of its 13C NMR data to that of 6 relative to 
those of 4 (Table 8). The structure of 21 was, thus, established as [PAC 4]-(4β → 6)-[PAC 6], and this assignment was further confirmed by 
the identification of 3 and 6 as the phloroglucinolysis products of 21 (Figure S106). 
Analysis of the 1H and 13C NMR spectra of 22 revealed that it was also an A + B + A-type tetrameric PAC with two major rotamers (∼2:1 
ratio). Units II and IV were assigned as (ent)-catechin and (ent)-epicatechin, respectively, based on the corresponding J2,3 values of 9.6 and 
∼0 Hz. A 2β → O → 7/4β → 8 linkage between units I and II was evident from the NOESY correlations (Figure S102) of I-H-4/II-H-2′ and 6′, as 
well as the high-amplitude CE at 220–240 nm in the ECD spectrum (Figure 4B). Similarly, the 2β → O → 7/4β → 8 A-type linkage between 
units III and IV was verified by the NOESY correlations of III-H-4/IV-H-2′ and 6′, as well as through ECD evidence. Units II and IV were 
connected by a 4β → 6 IFL based on the ECD data and the NOESY cross-peaks from III-H-8 to III-H-2′/6′, as well as through the specific 
chemical shift of III-C-8 (δC 111.6). Trans-configuration for H-3 and H-4 in both the C- and I-rings was verified by the NOESY correlations from 
H-3 (C- and I-ring) to H-6 (D- and J-ring). The cis-configuration between H-2 and H-4 in the F-ring was determined via the chemical shift of II-
C-2 (δC 84.6). Thus, units I and II had to be doubly linked as in 5. The ΔδC method was used to determine the absolute configuration of unit 
IV. Unit IV was identified as ent-epicatechin based on the closer resemblance of its 13C NMR resonance patterns with those of corresponding 
carbons in 6 rather than with those in 4 (Table 8). Collectively, this verified the structure of 22 to be [PAC 5]-(4β → 6)-[PAC 6]. 
Conclusions 
The presented combination of chiral spectroscopic (ECD) and chemical (phloroglucinolysis and MS and chiral phase HPLC) analyses 
generated the necessary framework of chiral reference data that enables the determination of absolute configuration of catechol 
monomers in oligomeric PACs by one-dimensional (1D) and 2D NMR. Access to the full three-dimensional (3D) structure of PAC trimers, 
tetramers, and even higher oligomers in their native, underivatized form is critical to establish structure–activity relationships from the 
subsequent biological evaluation, such as for the dentin biomodification potential of the compounds presented here, which were isolated 
from fractions with known bioactivity. The presented structural data expand both our prior reports(9−11) as well as other PAC literatures by 
providing accurately and precisely assigned 13C NMR resonances. This forms the knowledge base for making absolute stereochemical 
assignments of PAC monomers via inclusion of the γ-gauche effect observed in the 13C NMR resonances of PACs, as well as the 
determination of differential 13C chemical shift values (s.c.s; ΔδC) relative to those in the terminal monomers and analogous dimers 
(here: 2 and 4–6). 
Forming part of a closely knit interdisciplinary approach to PACs as dentin biomodification agents, the present but also previous and 
ongoing studies have frequently pointed out that the structural complexity of PACs is paired with substantial heterogeneity of the PAC 
literature in terms of the interplay between reported biological/bioactivity and chemistry/structural information. In this context, robust 
NMR data play a key role in being most significant for rigor and reproducibility: accurate and precise 1H and 13C assignments and shared 
spectra are key to achieving consistency among the chemical space of PACs and their biological profiles. While the relatively close 
resemblance of the spectra of analogous compounds adds to the challenge, the presented outcomes show how unambiguous assignments 
can transform potentially confusing spectral similarity into definitive structural information. It should be noted that the presence of 
atropisomeric forms not only dictates the use of low-temperature NMR but also poses a challenge in terms of PAC separation, which can be 
addressed by applying multiple steps and utilizing a variety of chromatographic techniques with as much as possible orthogonal character 
(here: countercurrent separation, silica gel-based, and Sephadex LH-20-based size-exclusion/adsorption CC, as well as semipreparative 
HPLC). 
The current study demonstrated the unambiguous elucidation of 13 trimeric and tetrameric PACs by combination of analytical approaches, 
including HRESIMS, low-temperature NMR, ECD, and phloroglucinolysis with MS and chiral phase HPLC to ensure the correct structure 
elucidated that use all techniques for each PAC oligomer. 
The detailed analysis of 13C NMR data proved to be a key element for achieving absolute stereochemical determination in the monomeric 
moieties in a series of diastereomeric PACs. Especially, the γ-gauche effect and consideration of s.c.s. effects via comparison of ΔδC values 
can corroborate assignments and help detect inconsistencies in the reported data. The presented structures can not only serve as well-
characterized components of a small PAC library for the further exploration of their dentin bioactivity but also contribute reliable, fully 
interpreted, and raw spectroscopic data to the available knowledge base. As high-quality structural data of trimeric and tetrameric PACs is 
in high demand, the presented outcomes also help avoid future ambiguous or erroneous assignments and increase structural 
reproducibility and integrity.(29) 
Experimental Section 
General Experimental Procedures 
High-resolution electrospray ionization mass spectrometric measurements were carried out by using a Bruker Impact II, quadrupole time of 
flight. ECD spectra were acquired on a JASCO-715 spectrometer with a 0.2 cm quartz cuvette, and the sample concentration was less than 
≤0.1 mg/mL in MeOH. All 1D/2D NMR spectra were acquired at 255 K, 278 K, and/or 298 K on an 800 MHz Bruker AVANCE spectrometer 
equipped with a 5 mm triple resonance inverse TCI RT probe. The 13C NMR spectra of all compounds were acquired on a JEOL (Jeol USA, 
Peabody, MA, USA). A ECZ 400 MHz spectrometer with an FTS cooling system that consists of XR AirJet and TC-84 temperature controller 
(SP Industries, Warminster, PA, USA). C18 reversed-phase (RP-18) silica gel (Macherey-Nagel, Bethlehem, PA, USA) and Sephadex LH-20 gel 
(Pharmacia, Uppsala, Sweden) were used for CC. TLC was performed on SIL G/UV254 (Macherey-Nagel, Inc., Bethlehem, PA, USA) with 
visualization under UV light (254 and 365 nm) and spraying with the vanillin–sulfuric acid reagent followed by heating. Semipreparative 
HPLC was performed on a Shimadzu HPLC (Kyoto, Japan) connected to a PDA detector (Shimadzu, model SPD-20A) and equipped with a 
YMC-Pack ODS-AQ (250 × 10 mm, S-5, 12 nm) or CHIRAPAK IA (250 × 10.0 mm, S-5 μm, Chiral Tech., West Chester, PA, USA). All solvents 
used were obtained from Fisher Scientific (Fair Lawn, NJ, USA) or Sigma-Aldrich (St. Louis, MO, USA). Phloroglucinol, ascorbic acid, hydrogen 
chloride, and sodium acetate used were of ACS grade and purchased from Sigma-Aldrich (St. Louis, MO, USA). All NMR solvents were 
purchased from Cambridge Isotope Laboratories (Tewksbury, MA, USA). 
Plant Material 
Extract powder of the inner bark of P. massoniana was purchased from Xi’an Chukang Biotechnology in China in 2012 (no. PB120212). 
Extraction and Isolation 
Enriched tri- and tetrameric PACs (12 g), being separated as 6.5 g of fraction A and 5.6 g of fraction B, were prepared from 200 g of the pine 
bark extract by CPC, as described previously.(12) Both CPC fractions A and B were chromatographed on a Sephadex LH-20 column (EtOH), 
affording corresponding 6 subfractions (A1–A6) and 7 subfractions (B1–B7), respectively. Fraction A1 (800 mg) contained mainly (±)-
catechin and (±)-epicatechin as confirmed by chiral phase HPLC. Fraction A2 (1.0 g) was fractionated over a RP-18 silica gel column 
(MeOH/H2O, 20–80%), and the major two subfractions A2b and A2c were then purified to afford compounds 2 (30 mg), 4 (20 mg), 5 (10 
mg), and 6 (10 mg) by the semipreparative HPLC (23% MeCN in 0.1% formic acid H2O, 2.5 mL/min, isocratic). Similarly, after being 
fractionated by the RP-18 silica gel column, compounds 15 (20 mg); 20 (2.8 mg) and 22 (0.9 mg); as well as 16 (12 mg) and 18 (7.1 mg) were 
purified from their corresponding fractions A3, A4, and A5, respectively, by semipreparative HPLC (23% MeCN in 0.1% formic acid H2O, 2.5 
mL/min, isocratic). Purification of A6 (1.5 g) via an RP-18 silica gel column (MeOH/H2O, 25–30%) led to the isolation of the major 
tetramer, 17 (900 mg). Fraction B5 (800 mg) was fractionated over a RP-18 silica gel column (MeOH/H2O, 20–80%), and the major three 
subfractions B5a–B5c were then purified via semipreparative HPLC (18% MeCN in 0.1% formic acid H2O, 2.5 mL/min) to afford 
compounds 11 (30 mg), 12 (1.5 mg), 13 (1.9 mg), and 14 (2.1 mg). Fraction B6 (1.6 g) mainly contained trimer 10 (700 mg), which was 
purified by a RP-18 silica gel column. Compounds 19 (25 mg) and 21 (2.0 mg) were purified from fraction B7 by semipreparative HPLC (20% 
MeCN in 0.1% formic acid H2O, 2.5 mL/min) after prefractionation with an RP-18 silica gel column. 
Epicatechin-(4β → 2)-phloroglucinol (1) 
Light brown, amorphous solid; ECD (MeOH) λmax (Δε) 203 (−9.6), 216 (+15.4), 237 (+9.3), 275 (−0.7) nm; 1H and 13C NMR (CD3OD, 255 K), 
see Table 1, HRMS (ESI) m/z: [M + H]+ calcd for C21H19O9, 415.1024; found, 415.1022. 
Epicatechin-(2β → O → 7,4β → 8)-catechin (2) 
Light brown, amorphous solid; ECD (MeOH) λmax (Δε) 208 (−6.8), 222 (+4.2), 272 (−1.4); 13C NMR (CD3OD, 298, 277, and 255 K), see Table 2; 
HRMS (ESI) m/z: [M + H]+ calcd for C30H25O12, 577.1341; found, 577.1360. 
Epicatechin-(2β → O → 7,4β → 8)-epicatechin-(4β → 2)-phloroglucinol (3) 
Light brown, amorphous solid; ECD (MeOH) λmax (Δε) 207 (−23.3), 227 (+20.6), 273 (−1.9); 1H and 13C NMR (CD3OD, 298 K), see Table 1; 
HRMS (ESI) m/z: [M + H]+ calcd for C36H29O15, 701.1501; found, 701.1504. 
Epicatechin-(2β → O → 7,4β → 8)-epicatechin (4) 
Light brown, amorphous solid; ECD (MeOH) λmax (Δε) 207 (−16.9), 222 (+10.4), 272 (−1.5); 13C NMR (CD3OD, 298, 277, and 255 K), 
see Table 2; HRMS (ESI) m/z: [M + H]+ calcd for C30H25O12, 577.1341; found, 577.1359. 
Epicatechin-(2β → O → 7,4β → 8)-ent-catechin (5) 
Light brown, amorphous solid; ECD (MeOH) λmax (Δε) 207 (−20.7), 224 (+12.7), 270 (−1.4); 13C NMR (CD3OD, 298, 277, and 255 K), 
see Table 2; HRMS (ESI) m/z: [M + H]+ calcd for C30H25O12, 577.1341; found, 577.1357. 
Epicatechin-(2β → O → 7,4β → 8)-ent-epicatechin (6) 
Light brown, amorphous solid; ECD (MeOH) λmax (Δε) 207 (−15.4), 222 (+15.0), 271 (−1.3); 13C NMR (CD3OD, 298, 277, and 255 K), 
see Table 2; HRMS (ESI) m/z: [M + H]+ calcd for C30H24O12, 577.1341; found, 577.1348. 
Epicatechin-(2β → O → 7,4β → 8)-ent-epicatechin-(4β → 2)-phloroglucinol (9) 
Light brown, amorphous solid; 1H and 13C NMR (CD3OD, 298 K), see Table 1; HRMS (ESI) m/z: [M + H]+ calcd for C36H29O15, 701.1501; found, 
701.1540. 
Epicatechin-(4β → 6)-epicatechin-(2β → O → 7,4β → 8)-catechin (10) 
Light brown, amorphous solid; ECD (MeOH) λmax (Δε) 212 (−6.6), 229 (+11); 272 (−1.1); 1H NMR (CD3OD, 255 K), see Table 3 and 13C NMR 
(CD3OD, 255 K), see Table 5, HRMS (ESI) m/z: [M + H]+ calcd for C45H37O18, 865.1974; found, 865.1996. 
Epicatechin-(4β → 8)-epicatechin-(2β → O → 7,4β → 8)-catechin (11) 
Light brown, amorphous solid; ECD (MeOH) λmax (Δε) 204 (−4.0), 224 (+6.3), 277 (−0.8); 1H NMR (CD3OD, 278 K), see Table 3 and 13C NMR 
(CD3OD, 278 K), see Table 5. HRMS (ESI) m/z: [M + H]+ calcd for C45H37O18, 865.1974; found 865.1983. 
Epicatechin-(4β → 8)-epicatechin-(2β → O → 7,4β → 8)-ent-epicatechin (12) 
Light brown, amorphous solid; ECD (MeOH) λmax (Δε) 205 (−8.5), 226 (+19.2), 274 (−2.2), 288 (+1.0); 1H NMR (CD3OD, 278 K), 
see Table 3 and 13C NMR (CD3OD, 278 K), see Table 5, HRMS (ESI) m/z: [M + H]+ calcd for C45H37O18, 865.1974; found, 865.1972. 
Epicatechin-(2β → O → 7,4β → 8)-epicatechin-(4β → 8)-catechin (13) 
Light brown, amorphous solid; ECD (MeOH) λmax (Δε) 208 (−13.7), 229 (+9.8), 272 (−1.1); 1H NMR (CD3OD, 278 K), see Table 3 and 13C NMR 
(CD3OD, 278 K), see Table 5, HRMS (ESI) m/z: [M + H]+ calcd for C45H37O18, 865.1974; found, 865.1966. 
Epicatechin-(2β → O → 7,4β → 8)-epiafzelechin-(4β → 8)-catechin (14) 
Light brown, amorphous solid; ECD (MeOH) λmax (Δε) 209 (−35.4), 230 (+29.3), 274 (−3.2); 1H NMR (CD3OD, 278 K), see Table 3 and 13C NMR 
(CD3OD, 278 K), see Table 5, HRMS (ESI) m/z: [M + H]+ calcd for C45H37O17, 849.2025; found, 849.2045. 
Epicatechin-(4β → 6)-epicatechin-(2β → O → 7,4β → 8)-epicatechin (15) 
Light brown, amorphous solid; ECD (MeOH) λmax (Δε) 212 (−6.6), 229 (+12.0), 272 (−1.1); 1H NMR (CD3OD, 255 K), see Table 4 and 13C NMR 
(CD3OD, 255 K), see Table 5, HRMS (ESI) m/z: [M + H]+ calcd for C45H37O18, 865.1974; found, 865.1960. 
Epicatechin-(2β → O → 7,4β → 8)-ent-catechin-(4β → 6)-catechin (16) 
Light brown, amorphous solid; ECD (MeOH) λmax (Δε) 204 (−12.8), 229 (+17.2), 274 (−1.3); 1H NMR (CD3OD, 278 K), see Table 4 and 13C NMR 
(CD3OD, 278 K), see Table 5, HRMS (ESI) m/z: [M + H]+ calcd for C45H37O18, 865.1974; found, 865.1978. 
Epicatechin-(2β → O → 7,4β → 8)-epicatechin-(4β → 6)-epicatechin-(2β → O → 7,4β → 8)-catechin (17) 
Light brown, amorphous solid; ECD (MeOH) λmax (Δε) 210 (−14.9), 225 (+14.1), 274 (−1.2); 1H NMR (CD3OD, 278 K), see Table 6 and 13C NMR 
(CD3OD, 278 K), see Table 7, HRMS (ESI) m/z: [M + H]+ calcd for C60H47O24, 1151.2452; found, 1151.2415. 
Epicatechin-(2β → O → 7,4β → 8)-epicatechin-(4β → 6)-epicatechin-(2β → O → 7,4β → 8)-epicatechin (18) 
Light brown, amorphous solid; ECD (MeOH) λmax (Δε) 209 (−18.2), 229 (+14.8), 273 (−1.1); 1H NMR (CD3OD, 278 K), see Table 6 and 13C NMR 
(CD3OD, 278 K), see Table 7, HRMS (ESI) m/z: [M + H]+ calcd for C60H47O24, 1151.2452; found, 1151.2468. 
Epicatechin-(2β → O → 7,4β → 8)-epicatechin-(4β → 8)-epicatechin-(2β → O → 7,4β → 8)-catechin (19) 
Light brown, amorphous solid; ECD (MeOH) λmax (Δε) 208 (−22.8), 229 (+20.4), 275 (−1.9); 1H NMR (CD3OD, 278 K), see Table 6 and 13C NMR 
(CD3OD, 278 K), see Table 7, HRMS (ESI) m/z: [M + H]+ calcd for C60H47O24, 1151.2452; found, 1151.2426. 
Epicatechin-(2β → O → 7,4β → 8)-epicatechin-(4β → 8)-epicatechin-(2β → O → 7,4β → 8)-epicatechin (20) 
Light brown, amorphous solid; ECD (MeOH) λmax (Δε) 208 (−30.1), 229 (+25.2), 274 (−2.3); 1H NMR (CD3OD, 278 K), see Table 6 and 13C NMR 
(CD3OD, 278 K), see Table 7, HRMS (ESI) m/z: [M + H]+ calcd for C60H47O24, 1151.2452; found, 1151.2484. 
Epicatechin-(2β → O → 7,4β → 8)-epicatechin-(4β → 6)-epicatechin-(2β → O → 7,4β → 8)-ent-epicatechin (21) 
Light brown, amorphous solid; ECD (MeOH) λmax (Δε) 206 (−8.2), 232 (+13.1), 273 (−0.8); 1H NMR (CD3OD, 278 K), see Table 6 and 13C NMR 
(CD3OD, 278 K), see Table 7, HRMS (ESI) m/z: [M + H]+ calcd for C60H47O24, 1151.2452; found, 1151.2484. 
Epicatechin-(2β → O → 7,4β → 8)-ent-catechin-(4β → 6)-epicatechin-(2β → O → 7,4β → 8)-ent-epicatechin (22) 
Light brown, amorphous solid; ECD (MeOH) λmax (Δε) 214 (+11.8), 225 (+9.7), 236 (+12.8), 273 (−1.5); 1H NMR (CD3OD, 278 K), 
see Table 4 and 13C NMR (CD3OD, 278 K), see Table 7, HRMS (ESI) m/z: [M + H]+ calcd for C60H47O24, 1151.2452; found, 1151.2427. 
Phloroglucinolysis 
To further confirm the configurations of all the isolated compounds, phloroglucinolysis was performed.(20) Compounds 10 (10 mg) 
and 17 (10 mg) were individually cleaved using a reaction mixture consisting of 400 mg of phloroglucinol and 100 mg of ascorbic acid in 10 
mL of 0.1 N HCl in MeOH at 50 °C for 30 min. Adding 50 mL of 40 mM sodium acetate solution to the mixture stopped the reaction. The 
mixture was then extracted twice with ethyl acetate, and the concentrated ethyl acetate layer was loaded onto Sephadex LH-20 for 
purification and resulted in the isolation of 1 and 2 from 10, as well as 2 and 3 from 17. Similarly, phloroglucinolysis of 11 (5.5 mg), 15 (3.1 
mg), 16 (2.8 mg), 18 (3.0 mg), and 19 (3.1 mg) by 100 mg of phloroglucinol and 50 mg of ascorbic acid in 5 mL of 0.1 N HCl in MeOH at 50 °C 
for 30 min was performed. Each reaction mixture was extracted by ethyl acetate, and then purified as corresponding two products as being 
confirmed by chiral phase HPLC and MS data. About 0.3–0.5 mg of 12–14, 20, and 21 were cleaved using a reaction mixture consisting of 20 
mg of phloroglucinol and 10 mg of ascorbic acid in 2 mL of 0.1 N HCl in MeOH at 50 °C for 30 min. The identity of all reaction products was 
confirmed by chiral phase HPLC and MS analysis. 
Dental Bioassay 
Dentin fragments were sectioned into 0.5 × 1.7 × 7.0 mm (H × W × L) pieces and demineralized using 10% phosphoric acid for 5 h. 
Specimens were treated with the compounds at 0.65% w/v in 20 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) buffer (pH 
7.2) for 1 h, and a control group was kept in HEPES buffer only (n = 5). The apparent modulus of elasticity (E) was measured using a 3-point 
bending method with a universal testing machine, as described previously.(31) Data were statistically evaluated by one-way ANOVA and 
Tukey’s post hoc tests (α = 0.05). 
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